The FDA proposed a rule to streamline establishment registration for distributed manufacturing using a hub-and-spoke model, allowing the network to register as a single establishment rather than requiring separate registrations for each unit. The proposal would also clarify registration and drug listing expectations for certain foreign sites supplying upstream components to other foreign establishments.